ReviewJCO global oncology2023
Breast Cancer in the United Arab Emirates.
Review in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Physical rehabilitation program for cardiorespiratory health and quality of life among breast cancer survivors in UAE: a randomized control trial.BMC cancer · 2025Trial
- Article
- Cost of Breast Cancer Treatment by Comorbidity in Dubai, the United Arab Emirates: A Retrospective Data Analytical Approach.European journal of breast health · 2026Article
- Evaluation of a student-led breast cancer awareness campaign as a co-curricular model in pharmacy education: a mixed-methods study in the UAE.BMC medical education · 2026Article
- Epidemiological Trends, Inequalities, and Projections of Breast and Gynecological Cancers in Older Asian Women.International journal of women's health · 2026Article
- Voices in practice: Exploring genetic counseling ethical, cultural, social, and religious dynamics in the UAE.Journal of genetic counseling · 2025Article
- Genetic characterization of BRCA1 and BRCA2 variants in cancer and high-risk family screening cohorts in the UAE population.Journal of cancer research and clinical oncology · 2025Article
- Experiences With Cancer Screenings Among Arabic-Speaking Refugee Women.Nursing for women's health · 2025Article
- Critical Diagnostic Delay Thresholds in Breast Cancer: A Molecular Subtype-Based Causal Analysis From Saudi Arabia.Cureus · 2025Article
- Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024.Frontiers in immunology · 2025Review
- Performance Metrics of Mammography Screening Programmes in Primary Health Care Centres in Bahrain.International journal of women's health · 2025Article
- Article
- Low testing rates and highWorld journal of clinical oncology · 2024Article
- Article
- Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer.Cancers · 2024Article
- BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region.Frontiers in oncology · 2024Review
- Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus.Frontiers in oncology · 2024Article
- Breast Cancer in the Arabian Gulf Countries.Cancers · 2023Review
- Article
- Identification of Breast Cancer LCK Proto-Oncogene as a Master Regulator of TNBC Neutrophil Enrichment and Polarization.International journal of molecular sciences · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.